1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Man-made Organ and Tissues Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Artificial Kidney
1.2.3 Artificial Heart & Ventricular Assist Device
1.2.4 Cochlear Implant
1.2.5 Artificial Lung
1.2.6 Artificial Liver
1.2.7 Artificial Pancreas
1.2.8 Bionic Hands & Prosthetics
1.2.9 Others
1.3 Market by Application
1.3.1 Global Man-made Organ and Tissues Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Use
1.3.3 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Man-made Organ and Tissues Market Perspective (2018-2029)
2.2 Man-made Organ and Tissues Growth Trends by Region
2.2.1 Global Man-made Organ and Tissues Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Man-made Organ and Tissues Historic Market Size by Region (2018-2023)
2.2.3 Man-made Organ and Tissues Forecasted Market Size by Region (2024-2029)
2.3 Man-made Organ and Tissues Market Dynamics
2.3.1 Man-made Organ and Tissues Industry Trends
2.3.2 Man-made Organ and Tissues Market Drivers
2.3.3 Man-made Organ and Tissues Market Challenges
2.3.4 Man-made Organ and Tissues Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Man-made Organ and Tissues Players by Revenue
3.1.1 Global Top Man-made Organ and Tissues Players by Revenue (2018-2023)
3.1.2 Global Man-made Organ and Tissues Revenue Market Share by Players (2018-2023)
3.2 Global Man-made Organ and Tissues Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Man-made Organ and Tissues Revenue
3.4 Global Man-made Organ and Tissues Market Concentration Ratio
3.4.1 Global Man-made Organ and Tissues Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Man-made Organ and Tissues Revenue in 2022
3.5 Man-made Organ and Tissues Key Players Head office and Area Served
3.6 Key Players Man-made Organ and Tissues Product Solution and Service
3.7 Date of Enter into Man-made Organ and Tissues Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Man-made Organ and Tissues Breakdown Data by Type
4.1 Global Man-made Organ and Tissues Historic Market Size by Type (2018-2023)
4.2 Global Man-made Organ and Tissues Forecasted Market Size by Type (2024-2029)
5 Man-made Organ and Tissues Breakdown Data by Application
5.1 Global Man-made Organ and Tissues Historic Market Size by Application (2018-2023)
5.2 Global Man-made Organ and Tissues Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Man-made Organ and Tissues Market Size (2018-2029)
6.2 North America Man-made Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Man-made Organ and Tissues Market Size by Country (2018-2023)
6.4 North America Man-made Organ and Tissues Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Man-made Organ and Tissues Market Size (2018-2029)
7.2 Europe Man-made Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Man-made Organ and Tissues Market Size by Country (2018-2023)
7.4 Europe Man-made Organ and Tissues Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Man-made Organ and Tissues Market Size (2018-2029)
8.2 Asia-Pacific Man-made Organ and Tissues Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Man-made Organ and Tissues Market Size by Region (2018-2023)
8.4 Asia-Pacific Man-made Organ and Tissues Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Man-made Organ and Tissues Market Size (2018-2029)
9.2 Latin America Man-made Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Man-made Organ and Tissues Market Size by Country (2018-2023)
9.4 Latin America Man-made Organ and Tissues Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Man-made Organ and Tissues Market Size (2018-2029)
10.2 Middle East & Africa Man-made Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Man-made Organ and Tissues Market Size by Country (2018-2023)
10.4 Middle East & Africa Man-made Organ and Tissues Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Detail
11.1.2 Fresenius Medical Care Business Overview
11.1.3 Fresenius Medical Care Man-made Organ and Tissues Introduction
11.1.4 Fresenius Medical Care Revenue in Man-made Organ and Tissues Business (2018-2023)
11.1.5 Fresenius Medical Care Recent Development
11.2 Cochlear
11.2.1 Cochlear Company Detail
11.2.2 Cochlear Business Overview
11.2.3 Cochlear Man-made Organ and Tissues Introduction
11.2.4 Cochlear Revenue in Man-made Organ and Tissues Business (2018-2023)
11.2.5 Cochlear Recent Development
11.3 Abiomed
11.3.1 Abiomed Company Detail
11.3.2 Abiomed Business Overview
11.3.3 Abiomed Man-made Organ and Tissues Introduction
11.3.4 Abiomed Revenue in Man-made Organ and Tissues Business (2018-2023)
11.3.5 Abiomed Recent Development
11.4 ABBOTT
11.4.1 ABBOTT Company Detail
11.4.2 ABBOTT Business Overview
11.4.3 ABBOTT Man-made Organ and Tissues Introduction
11.4.4 ABBOTT Revenue in Man-made Organ and Tissues Business (2018-2023)
11.4.5 ABBOTT Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Man-made Organ and Tissues Introduction
11.5.4 Baxter Revenue in Man-made Organ and Tissues Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 B.Braun
11.6.1 B.Braun Company Detail
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Man-made Organ and Tissues Introduction
11.6.4 B.Braun Revenue in Man-made Organ and Tissues Business (2018-2023)
11.6.5 B.Braun Recent Development
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Detail
11.7.2 Asahi Kasei Corporation Business Overview
11.7.3 Asahi Kasei Corporation Man-made Organ and Tissues Introduction
11.7.4 Asahi Kasei Corporation Revenue in Man-made Organ and Tissues Business (2018-2023)
11.7.5 Asahi Kasei Corporation Recent Development
11.8 Nipro
11.8.1 Nipro Company Detail
11.8.2 Nipro Business Overview
11.8.3 Nipro Man-made Organ and Tissues Introduction
11.8.4 Nipro Revenue in Man-made Organ and Tissues Business (2018-2023)
11.8.5 Nipro Recent Development
11.9 MED-EL
11.9.1 MED-EL Company Detail
11.9.2 MED-EL Business Overview
11.9.3 MED-EL Man-made Organ and Tissues Introduction
11.9.4 MED-EL Revenue in Man-made Organ and Tissues Business (2018-2023)
11.9.5 MED-EL Recent Development
11.10 Toray Medical
11.10.1 Toray Medical Company Detail
11.10.2 Toray Medical Business Overview
11.10.3 Toray Medical Man-made Organ and Tissues Introduction
11.10.4 Toray Medical Revenue in Man-made Organ and Tissues Business (2018-2023)
11.10.5 Toray Medical Recent Development
11.11 Sonova
11.11.1 Sonova Company Detail
11.11.2 Sonova Business Overview
11.11.3 Sonova Man-made Organ and Tissues Introduction
11.11.4 Sonova Revenue in Man-made Organ and Tissues Business (2018-2023)
11.11.5 Sonova Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Man-made Organ and Tissues Introduction
11.12.4 Medtronic Revenue in Man-made Organ and Tissues Business (2018-2023)
11.12.5 Medtronic Recent Development
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Detail
11.13.2 Getinge (Maquet) Business Overview
11.13.3 Getinge (Maquet) Man-made Organ and Tissues Introduction
11.13.4 Getinge (Maquet) Revenue in Man-made Organ and Tissues Business (2018-2023)
11.13.5 Getinge (Maquet) Recent Development
11.14 William Demant
11.14.1 William Demant Company Detail
11.14.2 William Demant Business Overview
11.14.3 William Demant Man-made Organ and Tissues Introduction
11.14.4 William Demant Revenue in Man-made Organ and Tissues Business (2018-2023)
11.14.5 William Demant Recent Development
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Detail
11.15.2 LivaNova (Sorin) Business Overview
11.15.3 LivaNova (Sorin) Man-made Organ and Tissues Introduction
11.15.4 LivaNova (Sorin) Revenue in Man-made Organ and Tissues Business (2018-2023)
11.15.5 LivaNova (Sorin) Recent Development
11.16 Terumo
11.16.1 Terumo Company Detail
11.16.2 Terumo Business Overview
11.16.3 Terumo Man-made Organ and Tissues Introduction
11.16.4 Terumo Revenue in Man-made Organ and Tissues Business (2018-2023)
11.16.5 Terumo Recent Development
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Detail
11.17.2 Hangzhou Nurotron Business Overview
11.17.3 Hangzhou Nurotron Man-made Organ and Tissues Introduction
11.17.4 Hangzhou Nurotron Revenue in Man-made Organ and Tissues Business (2018-2023)
11.17.5 Hangzhou Nurotron Recent Development
11.18 Syncardia
11.18.1 Syncardia Company Detail
11.18.2 Syncardia Business Overview
11.18.3 Syncardia Man-made Organ and Tissues Introduction
11.18.4 Syncardia Revenue in Man-made Organ and Tissues Business (2018-2023)
11.18.5 Syncardia Recent Development
11.19 CorWave
11.19.1 CorWave Company Detail
11.19.2 CorWave Business Overview
11.19.3 CorWave Man-made Organ and Tissues Introduction
11.19.4 CorWave Revenue in Man-made Organ and Tissues Business (2018-2023)
11.19.5 CorWave Recent Development
11.20 Listent Medical
11.20.1 Listent Medical Company Detail
11.20.2 Listent Medical Business Overview
11.20.3 Listent Medical Man-made Organ and Tissues Introduction
11.20.4 Listent Medical Revenue in Man-made Organ and Tissues Business (2018-2023)
11.20.5 Listent Medical Recent Development
11.21 Evaheart
11.21.1 Evaheart Company Detail
11.21.2 Evaheart Business Overview
11.21.3 Evaheart Man-made Organ and Tissues Introduction
11.21.4 Evaheart Revenue in Man-made Organ and Tissues Business (2018-2023)
11.21.5 Evaheart Recent Development
11.22 Open Bionics
11.22.1 Open Bionics Company Detail
11.22.2 Open Bionics Business Overview
11.22.3 Open Bionics Man-made Organ and Tissues Introduction
11.22.4 Open Bionics Revenue in Man-made Organ and Tissues Business (2018-2023)
11.22.5 Open Bionics Recent Development
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Detail
11.23.2 OYMotion Technologies Business Overview
11.23.3 OYMotion Technologies Man-made Organ and Tissues Introduction
11.23.4 OYMotion Technologies Revenue in Man-made Organ and Tissues Business (2018-2023)
11.23.5 OYMotion Technologies Recent Development
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Detail
11.24.2 Mobius Bionics Business Overview
11.24.3 Mobius Bionics Man-made Organ and Tissues Introduction
11.24.4 Mobius Bionics Revenue in Man-made Organ and Tissues Business (2018-2023)
11.24.5 Mobius Bionics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| ※参考情報 人工器官や人工組織は、生体の機能を模倣または代替するために設計されたものです。これらの技術は、医療分野において急速に進化しており、患者の生活の質を向上させるための重要な手段となっています。以下に、人工器官および組織の定義、特徴、種類、用途、関連技術について詳しく説明いたします。 まず、人工器官の定義から始めましょう。人工器官とは、体内の機能を補完または置き換えることを目的とした合成物であり、多くの場合、生体材料や生体適合性材料を使用して製造されます。一方、人工組織は、特定の機能を持つ細胞の集まりであり、組織の再生や修復を目指しています。これらは、体内に移植することができる場合もあれば、体外で使用される場合もあります。 人工器官と人工組織の特徴には、以下のような点が挙げられます。まず、これらは生体適合性が求められます。すなわち、体内に移植した際に免疫反応を引き起こさず、周囲の組織と適切に相互作用する必要があります。また、機能的な条件を満たしながら、長期間にわたって安定して動作することも重要です。さらに、設計や製造においては、細胞培養や組織工学の技術が利用され、ナノテクノロジーや3Dプリンティングも活用されています。 人工器官の種類としては、主に以下のものが挙げられます。人工心臓や人工肝臓、人工腎臓、人工膵臓、人工肺などがあります。人工心臓は、心臓移植が困難な患者に対して心機能を補完する装置であり、様々なタイプがあります。人工肝臓は、肝不全患者に対して肝機能を補助することを目指しており、臨床試験が進められています。人工腎臓は、透析治療の代替手段として注目されています。人工膵臓は、糖尿病患者に対してインスリン分泌機能を模倣するもので、血糖値を安定化させる効果が期待されています。人工肺は、呼吸不全の患者に対して酸素供給を行う役割を果たします。 人工組織の種類には、皮膚や軟骨、骨、血管、神経組織などがあります。皮膚組織は、傷の治癒や再生の促進に寄与するもので、焼傷や外傷後の治療に対応します。軟骨組織は、関節の機能を再生することを目指しており、関節炎などの治療に応用されています。骨組織は、骨折や骨欠損の治療に用いられるもので、再生医療の重要な対象です。血管組織は、血管の再生やバイパス手術に利用され、心血管疾患の治療において重要な役割を果たします。神経組織に関しては、神経損傷の治療や神経再生を目的とした技術が研究されています。 人工器官や組織の用途は多岐にわたります。まず、慢性疾患や重篤な外傷を抱える患者に対して、機能の補完や代替が行われ、生活の質を向上させます。また、移植待機中の患者に対する一時的なサポートとしても利用されることがあります。さらに、再生医療の分野では、損傷した組織や器官を修復する手段として期待されています。特に、がん治療や感染症の治療においても、人工組織が役立つケースが増えてきています。 関連技術としては、バイオマテリアルや細胞培養技術、バイオプリンティング、3D印刷技術、そして再生医療の進歩が重要です。バイオマテリアルは、生体材料として用いるための材料であり、生体適合性と機能性の両立が求められます。細胞培養技術は、細胞を体外で増殖させ、人工組織を構築するための基盤技術です。バイオプリンティングや3D印刷は、複雑な組織構造を持つ人工器官や組織を創り出すための革新技術として注目されています。 このように、人工器官や人工組織は、医療の未来を大きく変える可能性を秘めています。自身の組織を再生することができ、より効果的な治療法を提供するための鍵を握っているといえるでしょう。技術の進歩によって、今後ますます多くの患者が救われることを期待しています。 |
